Skip to content

Investigating the impact of a comprehensive nurse support program on death anxiety and compliance with hormone therapy in women with breast cancer

Investigating the impact of a comprehensive nurse support program on death anxiety and compliance with hormone therapy in women with breast cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240120060738N1
Enrollment
70
Registered
2024-01-28
Start date
2024-02-09
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: intervention group 6 sessions (small group of 5 to 7 people) face-to-face for 45 to 60 minutes (in the training classes of the Breast Clinic) and non-face-to-face (

Sponsors

Jahrom University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women with primary breast cancer Completing the course of surgery, chemotherapy and radiotherapy be under hormone therapy (any hormone medication) for at least one year In the last six months, she did not undergo any intervention regarding medication compliance or anxiety reduction Access to a mobile phone and the ability to use it Ability to perform physical activity

Exclusion criteria

Exclusion criteria: Failure to respond to follow-up calls or unwillingness to continue studying Discontinuation of medication due to side effects Recurrence of the disease in one of the organs Severe crisis in life

Design outcomes

Primary

MeasureTime frame
Adherence to drug treatment. Timepoint: Before and after the intervention. Method of measurement: Questionnaire of compliance with Moriski's drug treatment.;Anxiety. Timepoint: Before and after the intervention. Method of measurement: Templer Death Anxiety Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Hojjat

Jahrom University of Medical Sciences

mohsenhojat.mh@gmai.com+98 71 5433 6085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Aug 22, 2026